Presynaptic receptor

Presynaptic receptors are a diverse group of proteins located on the presynaptic nerve terminal that regulate the release of neurotransmitters into the synaptic cleft (StatPearls, 2023). They include autoreceptors, which provide feedback inhibition by responding to the neuron's own neurotransmitter, and heteroreceptors, which respond to signals from adjacent neurons (Starke, 2001). These receptors are critical therapeutic targets; for example, alpha-2 adrenergic receptors are targeted by drugs like clonidine for hypertension and pain, while the synaptic vesicle protein 2A (SV2A) is the target for the antiepileptic drug levetiracetam (Lynch et al., 2004). Additionally, certain presynaptic receptors, such as SV2 and synaptotagmin, serve as high-affinity binding sites for botulinum neurotoxins, facilitating their entry into the neuron (Pirazzini et al., 2017). Dysregulation of these receptors is associated with various neurological conditions, including epilepsy, chronic pain, and neurodegenerative diseases. By modulating ion channel activity or intracellular signaling pathways, these receptors fine-tune synaptic strength and plasticity, making them essential for normal nervous system function.

Other names

Presynaptic binding receptorsPresynaptic receptorPresynaptic binding sitePresynaptic acceptorAutoreceptorHeteroreceptorPresynaptic terminal receptor

Drugs targeting presynaptic receptors typically act as agonists or antagonists to modulate the probability of neurotransmitter release. Agonism of presynaptic autoreceptors (e.g., Alpha-2, GABA-B) generally inhibits further neurotransmitter release via G-protein coupled pathways that close voltage-gated calcium channels or open potassium channels. Conversely, some drugs bind to presynaptic proteins (e.g., SV2A) to modulate vesicle exocytosis directly or serve as a gateway for toxin entry into the neuron.